Results
|
|
7221.
|
|
|
|
7222.
|
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium. [electronic resource] by
- Deng, L
- Xu-Monette, Z Y
- Loghavi, S
- Manyam, G C
- Xia, Y
- Visco, C
- Huh, J
- Zhang, L
- Zhai, Q
- Wang, Y
- Qiu, L
- Dybkær, K
- Chiu, A
- Perry, A M
- Zhang, S
- Tzankov, A
- Rao, H
- Abramson, J
- Sohani, A R
- Xu, M
- Hsi, E D
- Zhu, J
- Ponzoni, M
- Wang, S
- Li, Ling
- Zhang, M
- Ferreri, A J M
- Parsons, B M
- Li, Y
- Piris, M A
- Medeiros, L J
- Young, K H
Producer: 20160722
In:
Leukemia vol. 30
Availability: No items available.
|
|
|
7223.
|
|
|
|
7224.
|
|
|
|
7225.
|
|
|
|
7226.
|
|
|
|
7227.
|
|
|
|
7228.
|
|
|
|
7229.
|
|
|
|
7230.
|
|
|
|
7231.
|
MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R. [electronic resource] by
- Lai, Catherine
- Roschewski, Mark
- Melani, Christopher
- Pittaluga, Stefania
- Shovlin, Margaret
- Steinberg, Seth M
- Dunleavy, Kieron
- Pack, Svetlana
- Jaffe, Elaine S
- Wilson, Wyndham H
Producer: 20181218
In:
Leukemia & lymphoma vol. 59
Availability: No items available.
|
|
|
7232.
|
|
|
|
7233.
|
|
|
|
7234.
|
Influence of FCGR3A-158V/F Genotype and Baseline CD20 Antigen Count on Target-Mediated Elimination of Rituximab in Patients with Chronic Lymphocytic Leukemia: A Study of FILO Group. [electronic resource] by
- Tout, Mira
- Gagez, Anne-Laure
- Leprêtre, Stéphane
- Gouilleux-Gruart, Valérie
- Azzopardi, Nicolas
- Delmer, Alain
- Mercier, Mélanie
- Ysebaert, Loïc
- Laribi, Kamel
- Gonzalez, Hugo
- Paintaud, Gilles
- Cartron, Guillaume
- Ternant, David
Producer: 20180221
In:
Clinical pharmacokinetics vol. 56
Availability: No items available.
|
|
|
7235.
|
|
|
|
7236.
|
|
|
|
7237.
|
|
|
|
7238.
|
Pharmacokinetics, safety, and efficacy of subcutaneous versus intravenous rituximab plus chemotherapy as treatment for chronic lymphocytic leukaemia (SAWYER): a phase 1b, open-label, randomised controlled non-inferiority trial. [electronic resource] by
- Assouline, Sarit
- Buccheri, Valeria
- Delmer, Alain
- Gaidano, Gianluca
- Trneny, Marek
- Berthillon, Natalia
- Brewster, Michael
- Catalani, Olivier
- Li, Sai
- McIntyre, Christine
- Sayyed, Pakeeza
- Badoux, Xavier
Producer: 20170710
In:
The Lancet. Haematology vol. 3
Availability: No items available.
|
|
|
7239.
|
|
|
|
7240.
|
Intrathecal rituximab for IgG [electronic resource] by
- Della-Torre, Emanuel
- Campochiaro, Corrado
- Cassione, Emanuele Bozzalla
- Albano, Luigi
- Gerevini, Simonetta
- Bianchi-Marzoli, Stefania
- Bozzolo, Enrica
- Passerini, Gabriella
- Lanzillotta, Marco
- Terreni, Mariarosa
- Callea, Marcella
- Trimarchi, Matteo
- Mortini, Pietro
- Tresoldi, Moreno
- Acerno, Stefania
- Dagna, Lorenzo
Producer: 20190708
In:
Journal of neurology, neurosurgery, and psychiatry vol. 89
Availability: No items available.
|